4.6 Article

Development of therapeutics for treatment of Ebola virus infection

Journal

MICROBES AND INFECTION
Volume 17, Issue 2, Pages 109-117

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.micinf.2014.11.012

Keywords

Ebola virus; Ebola virus disease; Therapeutics; Treatment; Antibody; Small-molecule compounds

Funding

  1. National Natural Science Foundation of China [81102476, 81173098]
  2. Shanghai Municipal Commission of Health and Family Planning [2013QLG009, 2013QLG010]

Ask authors/readers for more resources

Ebola virus infection can cause Ebola virus disease (EVD). Patients usually show severe symptoms, and the fatality rate can reach up to 90%. No licensed medicine is available. In this review, development of therapeutics for treatment of Ebola virus infection and EVD will be discussed. (C) 2014 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available